Shelia Violette Email

Founder & Chief Scientific Officer . Q32 Bio

Cambridge, MA

Location

LinkedIn

Current Roles

Employees:
45
Revenue:
$7M
About
Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases. Focused on the IL-7 pathway and complement system, Q32 Bio is addressing dysregulation to help patients take back control of their lives in diseases with few to no treatment options, or those diseases where current therapeutics provide inadequate relief.
Q32 Bio Address
830 Winter St
Cambridge, MA
United States
Q32 Bio Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.